Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited)

v3.19.3
Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 17,502 $ 4 $ 128,566,960 $ (169,180,425) $ (40,613,461)
Balance, shares at Dec. 31, 2017 1,750,275 39,501      
Common stock issued in cashless exercise of warrants $ 15 (15)
Common stock issued in cashless exercise of warrants, shares 151,200      
Conversion of debentures into common stock $ 67 3,056,607 3,056,674
Conversion of debentures into common stock, shares 666,621      
Stock-based compensation 24,196 24,196
Restricted stock issued to employees $ 14 641,096 641,110
Restricted stock issued to employees, shares 142,667      
Shares returned to treasury
Shares returned to treasury, shares (5)      
Beneficial conversion feature of Series 1-2 preferred stock (651,562) (651,562)
Conversion of Series I-2 Preferred stock into common stock        
Modification of warrants        
Net loss (146,364,584) (146,364,584)
Balance at Mar. 31, 2018 $ 17,502 $ 100 131,637,282 (315,545,009) (183,907,627)
Balance, shares at Mar. 31, 2018 1,750,275 999,984      
Balance at Dec. 31, 2017 $ 17,502 $ 4 128,566,960 (169,180,425) (40,613,461)
Balance, shares at Dec. 31, 2017 1,750,275 39,501      
Conversion of Series I-2 Preferred stock into common stock, shares   106,335,991      
Balance at Dec. 31, 2018 $ 20,002 $ 12,857 375,845,883 (415,046,606) (39,167,864)
Balance, shares at Dec. 31, 2018 2,000,225 128,567,273      
Common stock issued in cashless exercise of warrants $ 11,961 (11,961)
Common stock issued in cashless exercise of warrants, shares 119,615,384      
Stock-based compensation 8,650 8,650
Deemed dividend from trigger of down round provision feature 123,861,587 (123,861,587)
Shares returned to treasury        
Conversion of Series I-2 Preferred stock into common stock $ 325,570 318,310 643,880
Conversion of Series I-2 Preferred stock into common stock, shares 3,255,700,000      
Modification of warrants 4,056,424 4,056,424
Net loss       (13,441,404) (13,441,404)
Balance at Mar. 31, 2019 $ 20,002 $ 350,388 $ 504,078,893 $ (552,349,597) $ (47,900,314)
Balance, shares at Mar. 31, 2019 2,000,225 3,503,882,657